Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients

Fig. 3

Prognostic significance of NTRS in glioma patients. a The cut-off value was determined by ROC analysis. Patients with a higher NTRS (> = 0.078) were classified as the NTRSHigh group, and those with a lower NTRS (< 0.078) were classified as the NTRSLow group. b survival analysis of glioma patients with a high NTRS (NTRSHigh) versus low NTRS (NTRSLow) in the training set and validation set. The hazard ratio was determined by the Mantel-Haenszel method, and the P value was determined by the chi-square test between the two groups. c, d Prognostic efficiency of NTRS in patients with different grades and subgroups. e ROC curves of the prediction of 2-year survival with NTRS and other markers in the training set and validation set

Back to article page
\